A detailed history of Blueshift Asset Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Blueshift Asset Management, LLC holds 1,325 shares of AMGN stock, worth $411,783. This represents 0.13% of its overall portfolio holdings.

Number of Shares
1,325
Holding current value
$411,783
% of portfolio
0.13%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$258.78 - $328.31 $342,883 - $435,010
1,325 New
1,325 $345,000
Q2 2023

Aug 15, 2023

BUY
$214.27 - $253.37 $481,250 - $569,069
2,246 New
2,246 $498,000
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $184,598 - $234,554
806 Added 84.31%
1,762 $462,000
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $214,583 - $242,011
956 New
956 $215,000
Q2 2022

Aug 12, 2022

SELL
$230.71 - $256.74 $1.27 Million - $1.42 Million
-5,516 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$219.27 - $242.57 $203,701 - $225,347
929 Added 20.25%
5,516 $1.33 Million
Q4 2021

Feb 11, 2022

SELL
$198.88 - $227.6 $1.68 Million - $1.92 Million
-8,456 Reduced 64.83%
4,587 $1.03 Million
Q3 2021

Nov 12, 2021

BUY
$212.27 - $248.7 $2.3 Million - $2.7 Million
10,852 Added 495.3%
13,043 $2.77 Million
Q2 2021

Aug 13, 2021

BUY
$233.58 - $259.14 $7,007 - $7,774
30 Added 1.39%
2,191 $534,000
Q1 2021

May 06, 2021

BUY
$221.91 - $258.6 $479,547 - $558,834
2,161 New
2,161 $538,000
Q2 2020

Aug 13, 2020

SELL
$197.81 - $242.74 $260,120 - $319,203
-1,315 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$182.24 - $241.7 $239,645 - $317,835
1,315 New
1,315 $267,000
Q4 2019

Feb 14, 2020

SELL
$189.21 - $243.2 $272,840 - $350,694
-1,442 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$174.11 - $208.62 $251,066 - $300,830
1,442 New
1,442 $279,000
Q1 2019

May 14, 2019

SELL
$180.87 - $203.88 $513,670 - $579,019
-2,840 Closed
0 $0
Q4 2018

Feb 12, 2019

BUY
$178.4 - $208.25 $506,656 - $591,430
2,840 New
2,840 $553,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $166B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Blueshift Asset Management, LLC Portfolio

Follow Blueshift Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blueshift Asset Management, LLC with notifications on news.